|
|
Volumn 23, Issue 25, 2005, Pages 6276-6277
|
|
Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: Does cisplatin versus carboplatin make a difference? [19]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CARBOPLATIN;
CISPLATIN;
GEMCITABINE;
PLATINUM;
TAXANE DERIVATIVE;
ANTINEOPLASTIC AGENT;
ADVANCED CANCER;
BLOOD TOXICITY;
CANCER CHEMOTHERAPY;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DRUG EFFICACY;
GERM CELL TUMOR;
HEAD AND NECK TUMOR;
HUMAN;
LETTER;
LUNG NON SMALL CELL CANCER;
MEDICAL SOCIETY;
META ANALYSIS;
NAUSEA;
NEPHROTOXICITY;
OVARY CANCER;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SYSTEMATIC REVIEW;
TREATMENT RESPONSE;
VOMITING;
LUNG TUMOR;
NOTE;
SURVIVAL;
TREATMENT OUTCOME;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARBOPLATIN;
CARCINOMA, NON-SMALL-CELL LUNG;
CISPLATIN;
CLINICAL TRIALS;
HUMANS;
LUNG NEOPLASMS;
META-ANALYSIS;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
|
|
EID: 24944459001
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.2005.02.0156 Document Type: Letter |
|
Times cited : (6)
|
|
References (6)
|
